Trump: Administration Will Bid on Drug Prices

President-elect Donald Trump criticized the pharmaceutical industry and said his administration will bid on drug prices at a press conference on Wednesday.

Pharmaceutical companies have “a lot of lobbies,” Trump said, adding that the country does “very little bidding” on prescription drug prices.

We’re the largest buyer of drugs in the world, but yet we don’t bid properly,” Trump said at a press conference in Trump Tower, his first since July and since winning the 2016 election. “We’re going to save billions of dollars over a period of time.”

During the campaign, Trump called for Medicare to negotiate drug costs. After being elected president, he told Time he would take on drug prices.

Negotiating Medicare drug prices is a proposal typically embraced by Democrats and rejected by Republicans. Current Health and Human Services Secretary Sylvia Burwell has called for Medicare to negotiate drug prices, but Rep. Tom Price (R-Ga.), Trump’s pick to lead HHS, has opposed it in the past.

Trump also criticized the industry for leaving the United States.

“We have to get our drug industry coming back,” he said.


Health Brief: GOP Announces Changes to Health Care Bill

House GOP leaders made tweaks to their Obamacare replacement legislation aimed at bolstering Republican support, but many skeptical conservatives remain opposed to the plan. The changes include giving states more flexibility with their Medicaid programs, phasing out Obamacare taxes sooner and increasing tax credits to help older Americans afford health insurance.

Health Brief: Week in Review & What’s Ahead

Speaker Paul Ryan’s Obamacare replacement plan got a boost Friday when leaders of the Republican Study Committee, the largest caucus in the House GOP, announced their support after the White House agreed to an amendment package that would give states the choice to block grant Medicaid rather than receive a per capita cap, and maintain work requirements for some program enrollees.

Load More